Skip to main content
Premium Trial:

Request an Annual Quote

Junk or Not?

In the wake of the publishing of the ENCODE project papers, researchers are discussing just what the investigators meant by reporting that 80 percent of the human genome is functional, and whether or not the idea of 'junk DNA' still stands.

At the Nature News blog, Brendan Maher writes that, in their papers, the ENCODE investigators do get more specific about what they mean by 'functional.' He writes that they found that 8 percent of the genome can be bound by a regulatory protein, in addition to the 1 percent that is protein coding itself. Then based on the completion of their sampling methods, the investigators estimate that there is another 11 percent of the genome with regulatory activity, bringing the total to 20 percent. "Perhaps the main conclusion should have been that 20% of the genome in some situation can directly influence gene expression and phenotype of at least one human cell type," Maher writes. "It's a far cry from 80%, but a substantial increase from 1%."

Michael Eisen at the University of California, Berkeley, says at his blog that the idea of 'junk DNA' has long been out of favor. "Nobody actually thinks that non-coding DNA is 'junk' any more," he says. "It's an idea that pretty much only appears in the popular press, and then only when someone announces that they have debunked it."

But Larry Moran from the University of Toronto says that the ENCODE project does not show that most of the genome isn't 'junk DNA.' He writes that "Eisen is wrong, junk DNA is alive and well. In fact almost 90% of our genome is junk."

In a separate post, Moran notes that "creationists are going to love this," referring to the ENCODE project's findings. Indeed, a post at Uncommon Descent, an intelligent design blog, says that the ENCODE papers are a "spectacular vindication" of intelligent design's theory that all DNA must have a purpose.

"This is going to make my life very complicated," Moran adds.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.